Jubilee Industries to unlock remaining shareholding in its Electronics Business Unit for S$21.4M
SINGAPORE, Mar 23, 2023 – (ACN Newswire) – Catalist-listed Jubilee Industries Holdings Ltd has entered…
SINGAPORE, Mar 23, 2023 – (ACN Newswire) – Catalist-listed Jubilee Industries Holdings Ltd has entered…
SINGAPORE, Mar 23, 2023 – (ACN Newswire) – Accrelist Ltd.’s 53.31%-owned subsidiary, Jubilee Industries Holdings…
Singapore, Mar 22, 2023 – (ACN Newswire) – BuildTech Asia (BTA), the leading platform for…
DUBAI, Mar 23, 2023 – (ACN Newswire) – The 24th edition of World Blockchain Summit…
OLD GREENWICH, Conn.–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced its estimated book…
TORONTO–(BUSINESS WIRE)–Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX:…
SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the…
SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
TIMISOARA, Romania, Mar 23, 2023 – (ACN Newswire) – Crypto.ro, a leading online platform for…
CHICAGO, IL, Mar 23, 2023 – (ACN Newswire) – Yowie World is about to get…
MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSE_AM: FOXO), a leader in commercializing epigenetic biomarkers of health and…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Positive monotherapy and combination therapy data from Phase 1 trial of first clinical program, TPST-1120,…
– REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and…
– SENTI-202 on track to submit an Investigational New Drug (IND) application in second half…
Company prioritizing pipeline to focus on CTIM-76 development and discontinuing ONA-XR program Cash runway extended…
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022 Combination…